686
Views
39
CrossRef citations to date
0
Altmetric
Review

Targeting PGC-1α to control energy homeostasis

, PhD & , PhD
Pages 1329-1338 | Published online: 02 Oct 2007

Bibliography

  • MARX J: Unraveling the causes of diabetes. Science (2002) 296(5568):686-689.
  • MOKDAD AH, FORD ES, BOWMAN BA et al.: Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA (2003) 289(1):76-79.
  • MOKDAD AH, FORD ES, BOWMAN BA et al.: The continuing increase of diabetes in the US. Diabetes Care (2001) 24(2):412.
  • MOKDAD AH, BOWMAN BA, FORD ES et al.: The continuing epidemics of obesity and diabetes in the United States. JAMA (2001) 286(10):1195-1200.
  • MOKDAD AH, SERDULA MK, DIETZ WH et al.: The continuing epidemic of obesity in the United States. JAMA (2000) 284(13):1650-1651.
  • PETERSEN KF, SHULMAN GI: Etiology of insulin resistance. Am. J. Med. (2006) 119(5 Suppl. 1):S10-S16.
  • SHULMAN GI: Cellular mechanisms of insulin resistance. J. Clin. Invest. (2000) 106(2):171-176.
  • HANDSCHIN C, RHEE J, LIN J et al.: An autoregulatory loop controls peroxisome proliferator-activated receptor γ coactivator 1a expression in muscle. Proc. Natl. Acad. Sci. USA (2003) 100(12):7111-7116.
  • KOVES TR, LI P, AN J et al.: PPARγ coactivator-1α-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency. J. Biol. Chem. (2005) 280(39):33588-33598.
  • WU Z, PUIGSERVER P, ANDERSSON U et al.: Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell (1999) 98(1):115-124.
  • MUOIO DM, NEWGARD CB: Obesity-related derangements in metabolic regulation. Annu. Rev. Biochem. (2006) 75(1):367-401.
  • HOTAMISLIGIL GS: Inflammation and metabolic disorders. Nature (2006) 444(7121):860-867.
  • WELLEN KE, HOTAMISLIGIL GS: Obesity-induced inflammatory changes in adipose tissue. J. Clin. Invest. (2003) 112(12):1785-1788.
  • OZCAN U, CAO Q, YILMAZ E et al.: Endoplasmic reticulum stress links obesity, insulin action, and Type 2 diabetes. Science (2004) 306(5695):457-461.
  • LOWELL BB, SHULMAN GI: Mitochondrial dysfunction and Type 2 diabetes. Science (2005) 307(5708):384-387.
  • KELLEY DE, HE J, MENSHIKOVA EV et al.: Dysfunction of mitochondria in human skeletal muscle in Type 2 diabetes. Diabetes (2002) 51(10):2944-2950.
  • PETERSEN KF, BEFROY D, DUFOUR S et al.: Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science (2003) 300(5622):1140-1142.
  • PETERSEN KF, DUFOUR S, BEFROY D et al.: Impaired mitochondrial activity in the insulin-resistant offspring of patients with Type 2 diabetes. N. Engl. J. Med. (2004) 350(7):664-671.
  • MOOTHA VK, LINDGREN CM, ERIKSSON K-F et al.: PGC-1a-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. (2003) 34:267-273.
  • PATTI ME, BUTTE AJ, CRUNKHORN S et al.: Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc. Natl. Acad. Sci. USA (2003) 100(14):8466-8471.
  • GOODPASTER BH, KATSIARAS A, KELLEY DE: Enhanced fat oxidation through physical activity is associated with improvements in insulin sensitivity in obesity. Diabetes (2003) 52(9):2191-2197.
  • LIN J, HANDSCHIN C, SPIEGELMAN BM: Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab. (2005) 1(6):361-370.
  • SCARPULLA RC: Transcriptional activators and coactivators in the nuclear control of mitochondrial function in mammalian cells. Gene (2002) 286(1):81-89.
  • PUIGSERVER P, WU Z, PARK CW et al.: A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell (1998) 92(6):829-839.
  • LIN J, WU H, TARR PT et al.: Transcriptional co-activator PGC-1[α] drives the formation of slow-twitch muscle fibres. Nature (2002) 418(6899):797-801.
  • MOOTHA VK, HANDSCHIN C, ARLOW D et al.: Err{α} and Gabpa/b specify PGC-1{α}-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc. Natl. Acad. Sci. USA (2004) 101(17):6570-6575.
  • HANDSCHIN C, KOBAYASHI YM, CHIN S et al.: PGC-1{α} regulates the neuromuscular junction program and ameliorates Duchenne muscular dystrophy. Genes Dev. (2007) 21(7):770-783.
  • LIN J, WU P-H, TARR PT et al.: Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1[α] null mice. Cell (2004) 119(1):121-135.
  • MICHAEL LF, WU Z, CHEATHAM RB et al.: Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1. Proc. Natl. Acad. Sci. USA (2001) 98(7):3820-3825.
  • LEONE TC, LEHMAN JJ, FINCK BN et al.: PGC-1α; deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol. (2005) 3(4):e101.
  • YOON JC, PUIGSERVER P, CHEN G et al.: Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature (2001) 413(6852):131-138.
  • PUIGSERVER P, RHEE J, DONOVAN J et al.: Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1[α] interaction. Nature (2003) 423(6939):550-555.
  • RHEE J, INOUE Y, YOON JC et al.: Regulation of hepatic fasting response by PPARγ coactivator-1α (PGC-1): requirement for hepatocyte nuclear factor 4α in gluconeogenesis. Proc. Natl. Acad. Sci. USA (2003) 100(7):4012-4017.
  • LERIN C, RODGERS JT, KALUME DE et al.: GCN5 acetyltransferase complex controls glucose metabolism through transcriptional repression of PGC-1[α]. Cell Metab. (2006) 3(6):429-438.
  • RODGERS JT, LERIN C, HAAS W et al.: Nutrient control of glucose homeostasis through a complex of PGC-1[α] and SIRT1. Nature (2005) 434(7029):113-118.
  • YOON JC, XU G, DEENEY JT et al.: Suppression of [β] cell energy metabolism and insulin release by PGC-1[α]. Dev. Cell (2003) 5(1):73-83.
  • LEHMAN JJ, BARGER PM, KOVACS A et al.: Peroxisome proliferator-activated receptor {γ} coactivator-1 promotes cardiac mitochondrial biogenesis. J. Clin. Invest. (2000) 106(7):847-856.
  • HUSS JM, TORRA IP, STAELS B et al.: Estrogen-related receptor {α} directs peroxisome proliferator-activated receptor {α} signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle. Mol. Cell. Biol. (2004) 24(20):9079-9091.
  • ARANY Z, NOVIKOV M, CHIN S et al.: Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-γ coactivator 1α. Proc. Natl. Acad. Sci. USA. (2006) 103(26):10086-10091.
  • RUSSELL AP, FEILCHENFELDT J, SCHREIBER S et al.: Endurance training in humans leads to fiber type-specific increases in levels of peroxisome proliferator-activated receptor-γ coactivator-1 and peroxisome proliferator-activated receptor-α in skeletal muscle. Diabetes (2003) 52(12):2874-2881.
  • RUSSELL AP, Feilchenfeldt J, Schreiber S et al.: Regulation of metabolic transcriptional co-activators and transcription factors with acute exercise. Diabetes (2003) 52(12):2874-2881.
  • CIVITARESE AE, CARLING S, HEILBRONN LK et al.: Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Med. (2007) 4(3):e76.
  • HERZIG S, LONG F, JHALA US et al.: CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature (2001) 413(6852):179-183.
  • WU Z, HUANG X, FENG Y et al.: Transducer of regulated CREB-binding proteins (TORCs) induce PGC-1α transcription and mitochondrial biogenesis in muscle cells. Proc. Natl. Acad. Sci. USA (2006) 103(39):14379-14384.
  • NISOLI E, CLEMENTI E, PAOLUCCI C et al.: Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science (2003) 299(5608):896-899.
  • NISOLI E, TONELLO C, CARDILE A et al.: Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science (2005) 310(5746):314-317.
  • VALERIO A, CARDILE A, COZZI V et al.: TNF-{α} downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents. J. Clin. Invest. (2006) 116(10):2791-2798.
  • REZNICK RM, SHULMAN GI: The role of AMP-activated protein kinase in mitochondrial biogenesis. J. Physiol. (Lond.) (2006) 574(1):33-39.
  • CZUBRYT MP, MCANALLY J, FISHMAN GI et al.: Regulation of peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) and mitochondrial function by MEF2 and HDAC5. Proc. Natl. Acad. Sci. USA (2003) 100(4):1711-1716.
  • PUIGSERVER P, RHEE J, LIN J et al.: Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPAR[γ] coactivator-1. Mol. Cell (2001) 8(5):971-982.
  • FAN M, RHEE J, ST-PIERRE J et al.: Suppression of mitochondrial respiration through recruitment of p160 myb binding protein to PGC-1{α}: modulation by p38 MAPK. Genes Dev. (2004) 18(3):278-289.
  • TEYSSIER C, MA H, EMTER R et al.: Activation of nuclear receptor coactivator PGC-1α by arginine methylation. Genes Dev. (2005) 19(12):1466-1473.
  • BAUR JA, PEARSON KJ, PRICE NL et al.: Resveratrol improves health and survival of mice on a high-calorie diet. Nature (2006) 444(7117):337-342.
  • GERHART-HINES Z, RODGERS JT, BARE O et al.: Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1α. EMBO J. (2007) 26(7):1913-1923.
  • LAGOUGE M, ARGMANN C, GERHART-HINES Z et al.: Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell (2006) 127(6):1109-1122.
  • MORINO K, PETERSEN KF, DUFOUR S et al.: Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J. Clin. Invest. (2005) 115(12):3587-3593.
  • LING C, POULSEN P, CARLSSON E et al.: Multiple environmental and genetic factors influence skeletal muscle PGC-1α and PGC-1β gene expression in twins. J. Clin. Invest. (2004) 114(10):1518-1526.
  • HARA K, TOBE K, OKADA T et al.: A genetic variation in the PGC-1 gene could confer insulin resistance and susceptibility to Type II diabetes. Diabetologia (2002) 45(5):740-743.
  • MULLER YL, BOGARDUS C, PEDERSEN O et al.: A Gly482Ser missense mutation in the peroxisome proliferator-activated receptor γ coactivator-1 is associated with altered lipid oxidation and early insulin secretion in Pima Indians. Diabetes (2003) 52(3):895-898.
  • VIMALESWARAN KS, RADHA V, GHOSH S et al.: Peroxisome proliferator-activated receptor-γ co-activator-1α (PGC-1α) gene polymorphisms and their relationship to Type 2 diabetes in Asian Indians. Diabetic Med. (2005) 22(11):1516-1521.
  • HAMMARSTEDT A, JANSSON PA, WESSLAU C et al.: Reduced expression of PGC-1 and insulin-signaling molecules in adipose tissue is associated with insulin resistance. Biochem. Biophys. Res. Comm. (2003) 301(2):578-582.
  • SEMPLE RK, CROWLEY VC, STEWTER CP et al.: Expression of the thermogenic nuclear hormone receptor coactivator PGC-1α is reduced in the adipose tissue of morbidly obese subjects. Int. J. Obes. Relat. Metab. Disord. (2004) 28(1):176-179.
  • WILSON-FRITCH L, NICOLORO S, CHOUINARD M et al.: Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. J. Clin. Invest. (2004) 114(9):1281-1289.
  • GARNIER A, FORTIN D, DELOMENIE C et al.: Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. J. Physiol. (2003) 551(2):491-501.
  • SANO M, IZUMI Y, HELENIUS K et al.: Menage-a-trois 1 is critical for the transcriptional function of PPAR[γ] coactivator 1. Cell Metab. (2007) 5(2):129-142.
  • SANO M, WANG SC, SHIRAI M et al.: Activation of cardiac Cdk9 represses PGC-1 and confers a predisposition to heart failure. EMBO J. (2004) 23(17):3559-3569.
  • HUSS JM, KELLY DP: Nuclear receptor signaling and cardiac energetics. Circ. Res. (2004) 95(6):568-578.
  • HUSS JM, KELLY DP: Mitochondrial energy metabolism in heart failure: a question of balance. J. Clin. Invest. (2005) 115(3):547-555.
  • CUI L, JEONG H, BOROVECKI F et al.: Transcriptional repression of PGC-1[α] by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell (2006) 127(1):59-69.
  • ST-PIERRE J, DRORI S, ULDRY M et al.: Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell (2006) 127(2):397-408.
  • SCHREIBER SN, EMTER R, HOCK MB et al.: The estrogen-related receptor α (ERRα) functions in PPARγ coactivator 1α (PGC-1α)-induced mitochondrial biogenesis. Proc. Natl. Acad. Sci. USA (2004) 101(17):6472-6477.
  • SCHREIBER SN, KNUTTI D, BROGLI K et al.: The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor estrogen-related receptor α (ERRα). J. Biol. Chem. (2003) 278(11):9013-9018.
  • WILLY PJ, MURRAY IR, QIAN J et al.: Regulation of PPARγ coactivator 1α (PGC-1α) signaling by an estrogen-related receptor α (ERRα) ligand. Proc. Natl. Acad. Sci. USA (2004) 101(24):8912-8917.
  • KALLEN J, SCHLAEPPI J-M, BITSCH F et al.: Evidence for ligand-independent transcriptional activation of the human estrogen-related receptor α (ERRα): crystal structure of ERR{α} ligand binding domain in complex with peroxisome proliferator-activated receptor coactivator-1{α}. J. Biol. Chem. (2004) 279(47):49330-49337.
  • SUZUKI T, MIKI Y, MORIYA T et al.: Estrogen-related receptor α in human breast carcinoma as a potent prognostic factor. Cancer Res. (2004) 64(13):4670-4676.
  • HORARD B, VANACKER JM: Estrogen receptor-related receptors: orphan receptors desperately seeking a ligand. J. Mol. Endocrinol. (2003) 31(3):349-357.
  • FUJIMURA T, TAKAHASHI S, URANO T et al.: Increased expression of estrogen-related receptor α (ERRα) is a negative prognostic predictor in human prostate cancer. Int. J. Cancer (2007) 120(11):2325-2330.
  • BOURAS T, FU M, SAUVE AA et al.: SIRT1 deacetylation and repression of p300 involves lysine residues 1020/1024 within the cell cycle regulatory domain 1. J. Biol. Chem. (2005) 280(11):10264-10276.
  • BRUNET A, SWEENEY LB, STURGILL JF et al.: Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science (2004) 303(5666):2011-2015.
  • LUO J, NIKOLAEV AY, IMAI S-I et al.: Negative control of p53 by Sir2[α] promotes cell survival under stress. Cell (2001) 107(2):137-148.
  • MOTTA MC, DIVECHA N, LEMIEUX M et al.: Mammalian SIRT1 represses forkhead transcription factors. Cell (2004) 116(4):551-563.
  • NEMOTO S, FERGUSSON MM, FINKEL T: SIRT1 Functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1α. J. Biol. Chem. (2005) 280(16):16456-16460.
  • PICARD F, KURTEV M, CHUNG N et al.: Sirt1 promotes fat mobilization in white adipocytes by repressing PPARα. Nature (2004) 429(6993):771-776.
  • VAN DER HORST A, TERTOOLEN LGJ, DE VRIES-SMITS LMM et al.: FOXO4 Is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2SIRT1. J. Biol. Chem. (2004) 279(28):28873-28879.
  • KAEBERLEIN M, MCVEY M, GUARENTE L: The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev. (1999) 13(19):2570-2580.
  • ROGINA B, HELFAND SL: Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc. Natl. Acad. Sci. USA (2004) 101(45):15998-16003.
  • ANDERSON RM, BITTERMAN KJ, WOOD JG et al.: Nicotinamide and PNC1 govern lifespan extension by calorie restriction in Saccharomyces cerevisiae. Nature (2003) 423(6936):181-185.
  • LIN S-J, DEFOSSEZ P-A, GUARENTE L: Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science (2000) 289(5487):2126-2128.
  • GUARENTE L, PICARD F: Calorie restriction – the SIR2 connection. Cell (2005) 120(4):473-482.
  • BORDONE L, MOTTA MC, PICARD F et al.: Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells. PLoS Biol. (2006) 4(2):E31.
  • MOYNIHAN KA, GRIMM AA, PLUEGER MM et al.: Increased dosage of mammalian Sir2 in pancreatic [α] cells enhances glucose-stimulated insulin secretion in mice. Cell Metab. (2005) 2(2):105-117.
  • COHEN HY, MILLER C, BITTERMAN KJ et al.: Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science (2004) 305(5682):390-392.
  • HEILBRONN LK, CIVITARESE AE, BOGACKA I et al.: Glucose tolerance and skeletal muscle gene expression in response to alternate day fasting. Obesity Res. (2005) 13(3):574-581.
  • HOWITZ KT, BITTERMAN KJ, COHEN HY et al.: Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature (2003) 425(6954):191-196.
  • HOUSTIS N, ROSEN ED, LANDER ES: Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature (2006) 440(7086):944-948.
  • WALLACE DC: A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. (2005) 39:359-407.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.